This filing is a routine governance update for the pending merger, no new financial or strategic information. Monitor for shareholder vote on these director appointments and any updates on merger closing conditions or regulatory approvals.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 31 $23.91entry
- T+1 · 3mo ago −3.51%α −2.83% · $23.07
- T+5 · 2mo ago −1.25%α −1.11% · $23.61
- T+20 · 7w ago −9.87%α −9.93% · $21.55
- T+54 · todayOpen
- T+60 · in 7d Pending
Price Chart
How similar events traded
Executive Summary
AkzoNobel and Axalta announced three additional non-executive directors for the combined company's board upon completion of their pending merger of equals. The appointments include a partner from activist fund Cevian Capital (Robert Schuchna), a Caterpillar Group President (Denise C. Johnson), and the retiring CEO of AptarGroup (Stephan B. Tanda). This is a routine governance step finalizing the board composition for the merger, with no financial terms or new strategic details disclosed.
Key Facts
- Three non-executive directors appointed to the combined company board: Stephan B. Tanda, Denise C. Johnson, and Robert Schuchna.
- Robert Schuchna is a partner at Cevian Capital, an activist fund, and currently serves on AkzoNobel's Supervisory Board.
- The combined company board will consist of 11 members, including Rakesh Sachdev (Chair), Ben Noteboom (Vice-Chair), Greg Poux-Guillaume (CEO), and Chris Villavarayan (Deputy CEO).
- Appointments are subject to shareholder approval at an Extraordinary General Meeting later this year.
- The merger of equals between AkzoNobel and Axalta remains pending, with a prospectus published on June 24, 2026.
Financial Impact
No financial figures disclosed. This is a governance filing with no deal value, revenue, or earnings data.
Risk Factors
- Merger closing conditions may not be satisfied or may be delayed.
- Shareholder approval for the new directors is required and not guaranteed.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0000950103-26-013227 |
| Document: dp252658_6k.htm | 0000950103-26-013227 |
| Document: 0000950103-26-013227-index-headers.html | 0000950103-26-013227 |
| Document: 0000950103-26-013227-index.html | 0000950103-26-013227 |
| Document: 0000950103-26-013227.txt | 0000950103-26-013227 |
Track record
14 reports on AKZOY
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +7.29% at T+20 after the Oct 5, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 4/10 Entry $23.19 to $23.18 Now $22.90 −1.25% ▼ −0.04% +0.32% vs SPY
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $23.30 to $23.97 Now $22.90 −1.72% ▲ +2.88% +0.51% vs SPY
- Oct 21, 202626d ago 6-K Neutral 5/10 No price data
- Oct 21, 202626d ago 6-K Neutral 4/10 No price data
- Oct 21, 202626d ago 6-K Neutral 4/10 Entry $22.83 to $22.59 Now $22.90 +0.31% ▼ −1.05% +0.13% vs SPY
- Oct 16, 20264w ago 6-K Neutral 4/10 Entry $22.03 to $21.95 Now $22.90 +3.95% ▼ −0.36% −0.79% vs SPY
- Oct 15, 20264w ago 6-K Neutral 3/10 Entry $22.03 to $21.95 Now $22.90 +3.95% ▼ −0.36% −0.79% vs SPY
- Oct 5, 20266w ago 6-K Bullish 6/10 Entry $21.53 to $21.87 Now $22.90 +6.36% ▲ +1.58% +1.03% vs SPY
- Aug 31, 202611w ago 6-K Neutral 3/10 Viewing Entry $23.91 to $23.07 Now $22.90 −4.22% ▼ −3.51% −2.83% vs SPY
- Jul 23, 202616w ago 6-K Neutral 3/10 Entry $21.28 to $21.93 Now $22.90 +7.61% ▲ +3.05% +2.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers